In addition, studies have shown the upregulation of Nrf2 and its target genes (AKR1c1, GCLC) in pancreatic cancer cell lines (Suit-2, MiaPaca-2, FAMPAC cells)[98]. The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.